Great Basin Scientific, Inc.
(Other OTC/NBB : GBSN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
TMOThermo Fisher Scientific, Inc. -0.82%597.161.0%$761.10m
DHRDanaher Corp. -1.00%297.470.7%$621.67m
ISRGIntuitive Surgical, Inc. -1.35%230.550.8%$506.59m
ABTAbbott Laboratories -1.06%110.840.8%$442.38m
MDTMedtronic Plc -0.48%94.850.6%$436.34m
SYKStryker Corp. -0.98%221.971.3%$381.73m
BSXBoston Scientific Corp. 0.11%42.401.0%$302.76m
DXCMDexCom, Inc. -2.68%88.361.9%$265.90m
ALGNAlign Technology, Inc. -3.51%278.916.4%$257.75m
EWEdwards Lifesciences Corp. -1.63%100.610.4%$248.91m
BDXBecton, Dickinson & Co. -1.21%264.541.0%$234.93m
IDXXIDEXX Laboratories, Inc. -1.69%375.803.9%$217.27m
BAXBaxter International, Inc. -0.53%61.511.8%$201.70m
MASIMasimo Corp. -1.89%166.185.1%$199.54m
AAgilent Technologies, Inc. 7.61%142.871.7%$186.22m

Company Profile

Great Basin Corporation is a privately held life sciences company. Great Basin Corporation commercializes breakthrough technologies for the molecular, rapid diagnostic testing market. Great Basin Corporation is dedicated to developing simple yet powerful point-of-care technology and products that improve automation, throughput, scalability, reliability and ease-of-use in rapid diagnostic testing. Great Basin’s technology—providing greater scalability of content—will empower health providers to diagnose infectious disease and define a clear treatment path sooner for improved patient outcomes, shorter hospital stays, and dollars saved in hospitalization costs per patient. This next-generation technology will ultimately limit the spread of deadly hospital-acquired superbugs by delivering pinpoint accuracy to diagnosis, significantly reducing medication errors, false positives, and antibiotic drug resistance. In short, we will bring this technology to doctors’ offices and pharmacies, making molecular testing so simple and cost effective that every patient will be tested for every serious infection, reducing misdiagnoses and significantly limiting the spread of infectious disease. Please visit our Technology and Product pages to learn more about our innovative approach to diagnostics.